Moving Forward: Your Guide to CAPRELSA

CAPRELSA (kap-rel-sah) is a prescription medicine for adults. It is the first FDA-approved medication to treat advanced medullary thyroid cancer (MTC).

CAPRELSA is used to treat MTC that cannot be removed by surgery or that has spread to other parts of the body, and the tumors are growing or causing symptoms. Because of the risks associated with CAPRELSA, your health care provider should carefully consider whether to prescribe CAPRELSA for you if your tumors are growing slowly or if you are not having symptoms. It takes a long time to get rid of CAPRELSA from your body and you may be at risk for side effects related to CAPRELSA after you have stopped your treatment.

Learn More
This information does not take the place of talking to your health care provider about your medical condition or treatment.

The most important information you need to know

CAPRELSA can cause a change in the electrical activity of your heart called QT prolongation, which can cause irregular heartbeats and that may lead to death. You should not take CAPRELSA if you have had a condition called long QT syndrome since birth.

Learn More About QT Prolongation

CAPRELSA Access Support Program

Have questions about insurance and paying for
CAPRELSA?

Find support from the CAPRELSA® Patient Access Support (CPAS) Program